Neal D. Shore, MD, FACS

Neal D. Shore, MD, FACS

Carolina Urologic Research Center and Atlantic Urology Clinics, LLC

Myrtle Beach, SC

Neal D. Shore, MD, FACS is the Medical Director for the Carolina Urologic Research Center. He practices with Atlantic Urology Clinics in Myrtle Beach, South Carolina. Dr. Shore has conducted more than 250 clinical trials, focusing mainly on GU Oncology, and serves on the Executive Boards of: Society of Urologic Oncology Board, Society of Urologic Oncology Clinical Trials Consortium, and the Large Urology Group Practice Association. He also is a member of the AUA Data Committee, the Bladder Cancer Advocacy Think Tank and the editorial board of Urology Times. He has numerous articles/peer reviewed publications and also performs peer review for more multiple journals. A graduate of Duke University Medical School, Dr. Shore completed a 6-month clinical research fellowship in Pretoria, South Africa, and then completed his General Surgery/Urology training at New York Hospital Cornell Medical Center and at Memorial Sloan-Kettering Cancer Center in New York City. He is a Fellow of the American College of Surgeons.

Articles by Neal D. Shore, MD, FACS

The Evolution of Understanding the USPSTF: Recommendations and Controversy

Dr. Neal Shore, MD, FACS, stands in for Deepak A. Kapoor, MD, at the 28th International Prostate Cancer Update, summarizing the history of the United States Preventive Services Task Force (USPSTF) and their Recommendation Grades for disease prevention and screening services. He explains the issues that arise when lawmakers attempt to use USPSTF recommendations as a basis for insurance laws. Specifically, he explains how healthcare policy effects PSA testing.

Read More

Prostatepedia October 2017, Volume 3, No. 2: Advances in Imaging

Prostatepedia features intimate conversations with doctors, patients and patient-advocates about all aspects of the prostate cancer journey. To subscribe and access the full content of this issue, visit their website here   Prostatepedia__October2017   Imaging is important for newly diagnosed prostate cancer patients who may or may not have localized disease, and it’s especially important for advanced prostate cancer patients, whether they continue to be androgen sensitive or have developed some level of androgen...

Read More

Other Side Effects: Perception vs. Evidence

These downloadable slides by Dr. Neal D. Shore, MD, FACS are on the topic of management of adverse effects in ADT for men with prostate cancer. These slides were presented at a satellite symposium presented in conjunction with the AUA Annual Meeting held on Sunday, May 14, 2017 entitled “Navigating the Adverse Effects of ADT: Improving Patient Outcomes”. Download...

Read More

Join the GRU Community

- Why Join? -